Steroid resistance and concomitant respiratory infections: A challenging battle in pulmonary clinic

No abstract is available for this paper.

• Publication year

  2017

• Venue

  EXCLI Journal : Experimental and Clinical Sciences

• Publication date

  2017-06-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.17179/excli2017-425PMID 28900378PMCID 5579404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA‐21 drives severe, steroid‐insensitive experimental asthma by amplifying phosphoinositide 3‐kinase–mediated suppression of histone deacetylase 2

  2017cited by this paper
• Bcl‐2 inhibitors reduce steroid‐insensitive airway inflammation

  2017cited by this paper
• Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma.

  2017cited by this paper
• Molecular Mechanisms of Airway Hyperresponsiveness in a Murine Model of Steroid-Resistant Airway Inflammation

  2016cited by this paper
• RAGE deficiency predisposes mice to virus-induced paucigranulocytic asthma

  2016influential reference
• NK cells contribute to persistent airway inflammation and AHR during the later stage of RSV infection in mice

  2016cited by this paper
• Determinants of host susceptibility to murine respiratory syncytial virus (RSV) disease identify a role for the innate immunity scavenger receptor MARCO gene in human infants

  2016cited by this paper
• Bromodomain and Extra Terminal (BET) Inhibitor Suppresses Macrophage-Driven Steroid-Resistant Exacerbations of Airway Hyper-Responsiveness and Inflammation

  2016cited by this paper
• Emerging pathogenic links between microbiota and the gut–lung axis

  2016cited by this paper
• MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases

  2016cited by this paper
• TNF-α and Macrophages Are Critical for Respiratory Syncytial Virus–Induced Exacerbations in a Mouse Model of Allergic Airways Disease

  2016cited by this paper
• Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma.

  2016cited by this paper
• A phase 1 randomized, double-blind, placebo-controlled, crossover trial of DAS181 (Fludase®) in adult subjects with well-controlled asthma

  2015cited by this paper
• Models of Respiratory Infections: Virus-Induced Asthma Exacerbations and Beyond

  2015cited by this paper
• Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease.

  2015cited by this paper
• Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol

  2015cited by this paper
• Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist

  2015influential reference
• Phase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults.

  2015cited by this paper
• MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity.

  2015cited by this paper
• 175: Interleukin-13 predisposes mice to more severe influenza infection by suppressing interferon responses and activating microRNA-21/PI3K

  2014cited by this paper
• Comparison of Temporal Transcriptomic Profiles from Immature Lungs of Two Rat Strains Reveals a Viral Response Signature Associated with Chronic Lung Dysfunction

  2014cited by this paper
• Pulmonary immunity during respiratory infections in early life and the development of severe asthma.

  2014cited by this paper
• Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease

  2013cited by this paper
• A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis.

  2013cited by this paper
• Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease

  2012cited by this paper
• A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection.

  2012cited by this paper
• Steroid resistance in severe asthma: current mechanisms and future treatment.

  2011cited by this paper
• Histone Deacetylase 2

  2011cited by this paper
• Role of viral respiratory infections in asthma and asthma exacerbations

  2010cited by this paper
• The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update

  2010cited by this paper
• Use of palivizumab in neonates who do not meet the American Academy of Pediatrics Guidelines for respiratory syncytial virus prophylaxis

  2009cited by this paper
• Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.

  2007cited by this paper
• Anti-Respiratory Syncytial Virus (RSV) Neutralizing Antibody Decreases Lung Inflammation, Airway Obstruction, and Airway Hyperresponsiveness in a Murine RSV Model

  2004cited by this paper
• [Guidelines for respiratory syncytial virus prophylaxis. An update].

  2002cited by this paper
• Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

  2000cited by this paper
• Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants.

  1998cited by this paper
• Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.

  1998cited by this paper

• Beyond the Obvious: Smoking and Respiratory Infection Implications on Alzheimer's Disease.

  2020cites this paper
• Advancing of Cellular Signaling Pathways in Respiratory Diseases Using Nanocarrier based Drug Delivery Systems.

  2020cites this paper
• The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress

  2019cites this paper
• Preparation, characterization and in-vitro efficacy of quercetin loaded liquid crystalline nanoparticles for the treatment of asthma

  2019cites this paper